Literature DB >> 21252747

Clinical significance of borderline amniotic fluid index and oligohydramnios in preterm pregnancy.

Loren N Petrozella1, Jodi S Dashe, Donald D McIntire, Kenneth J Leveno.   

Abstract

OBJECTIVE: To estimate pregnancy and neonatal outcomes in women with decreased amniotic fluid index (AFI) between 24 and 34 weeks of gestation, compared with outcomes in those with normal AFI.
METHODS: This is a review of singleton pregnancies that received ultrasound examinations at 24-34 weeks from 1997 to 2008. If more than one ultrasound examination was performed, the lowest AFI was used for analysis. An AFI 5 cm or less was considered oligohydramnios, 5-8 cm was considered borderline, and more than 8 cm to 24 cm was considered normal. Women with hydramnios or ruptured membranes at time of ultrasound examination were excluded.
RESULTS: A total of 28,555 pregnancies met inclusion criteria. Ultrasound examination had been performed to estimate gestational age or evaluate fetal growth in 78%. Major malformations were more common in pregnancies with oligohydramnios and borderline AFI than in those with normal fluid-25%, 10%, and 2%, respectively, P<.001. Among nonanomalous fetuses, complications that occurred more often in pregnancies with oligohydramnios and borderline AFI than in those with normal fluid included preterm birth (62%, 37%, 8%), either indicated (20%, 13%, 2%) or resulting from spontaneous preterm labor (42%, 24%, 6%); cesarean delivery for nonreassuring fetal status (9%, 9%, 4%), and birth weight below the third percentile (37%, 21%, 4%), all P<.001.
CONCLUSION: Pregnancies with decreased AFI between 24 and 34 weeks, including borderline AFI as well as oligohydramnios, were significantly more likely to be associated with major fetal malformations, and in the absence of malformations, to be complicated by fetal growth restriction and preterm birth. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Year:  2011        PMID: 21252747     DOI: 10.1097/AOG.0b013e3182056766

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis.

Authors:  Gordon Cs Smith; Alexandros A Moraitis; David Wastlund; Jim G Thornton; Aris Papageorghiou; Julia Sanders; Alexander Ep Heazell; Stephen C Robson; Ulla Sovio; Peter Brocklehurst; Edward Cf Wilson
Journal:  Health Technol Assess       Date:  2021-02       Impact factor: 4.014

2.  Comparison of the effect of betamethasone versus dexamethasone on the amniotic fluid index in the women at risk of preterm labor.

Authors:  Hatav Ghasemi Tehrani; Behnaz Khani; Zahra Komrani
Journal:  J Res Med Sci       Date:  2014-12       Impact factor: 1.852

3.  Perinatal outcomes of pregnancies with borderline versus normal amniotic fluid index.

Authors:  Maryam Asgharnia; Roya Faraji; Fatemeh Salamat; Babak Ashrafkhani; Seyedeh Fatemeh Dalil Heirati; Samira Naimian
Journal:  Iran J Reprod Med       Date:  2013-09

Review 4.  Amniotic fluid as a vital sign for fetal wellbeing.

Authors:  Elizabeth A Dubil; Everett F Magann
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

5.  Adverse perinatal outcomes in borderline amniotic fluid index.

Authors:  Ashraf Jamal; Maryam Kazemi; Vajiheh Marsoosi; Laleh Eslamian
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-11

6.  Comparison of Perinatal and Maternal Outcomes in Borderline Versus Normal Amniotic Fluid Index in a Tertiary Care Center in Odisha: An Observational Prospective Study.

Authors:  Anuradha Vyas; G Prasanna; Sudarshan Dash; Sudhansu Rath
Journal:  Cureus       Date:  2021-11-24

7.  Evaluation of Maternal and Perinatal Outcomes of Induction in Borderline Oligohydramnios at Term.

Authors:  Setu Rathod; Sunil Kumar Samal
Journal:  J Clin Diagn Res       Date:  2017-09-01

8.  Efficacy of Lactoferrin Oral Administration in the Treatment of Anemia and Anemia of Inflammation in Pregnant and Non-pregnant Women: An Interventional Study.

Authors:  Maria Stefania Lepanto; Luigi Rosa; Antimo Cutone; Maria Pia Conte; Rosalba Paesano; Piera Valenti
Journal:  Front Immunol       Date:  2018-09-21       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.